Can we eliminate placebo in ALS clinical trials?
Bryan WW, Hoagland RJ, Murphy J, Armon C, Barohn RJ, Goodpasture JC, Miller RG, Parry GJ, Petajan JH, Ross MA, Stromatt SC; rhCNTF ALS Study Group.
Bryan WW, et al. Among authors: stromatt sc.
Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Apr;4(1):11-5. doi: 10.1080/14660820310006661.
Amyotroph Lateral Scler Other Motor Neuron Disord. 2003.
PMID: 12745612
Clinical Trial.